Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-041170
Filing Date
2025-03-18
Accepted
2025-03-18 16:05:31
Documents
90
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K stok-20241231.htm   iXBRL 10-K 3132664
2 EX-4.2 stok-ex4_2.htm EX-4.2 44709
3 EX-10.20 stok-ex10_20.htm EX-10.20 22603
4 EX-19.1 stok-ex19_1.htm EX-19.1 168625
5 EX-23.1 stok-ex23_1.htm EX-23.1 2988
6 EX-31.1 stok-ex31_1.htm EX-31.1 17637
7 EX-31.2 stok-ex31_2.htm EX-31.2 17653
8 EX-32.1 stok-ex32_1.htm EX-32.1 9007
9 EX-32.2 stok-ex32_2.htm EX-32.2 8872
10 GRAPHIC img145368335_0.jpg GRAPHIC 241881
11 GRAPHIC img145368335_1.jpg GRAPHIC 510736
12 GRAPHIC img145368335_2.jpg GRAPHIC 103233
13 GRAPHIC img145368335_3.jpg GRAPHIC 153745
14 GRAPHIC img145368335_4.jpg GRAPHIC 73745
15 GRAPHIC img145368335_5.jpg GRAPHIC 748875
16 GRAPHIC img145368335_6.jpg GRAPHIC 85742
  Complete submission text file 0000950170-25-041170.txt   15961432

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT stok-20241231.xsd EX-101.SCH 1250566
92 EXTRACTED XBRL INSTANCE DOCUMENT stok-20241231_htm.xml XML 1919411
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38938 | Film No.: 25748244
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)